journal
MENU ▼
Read by QxMD icon Read
search

Lancet Diabetes & Endocrinology

journal
https://www.readbyqxmd.com/read/28483371/pcsk9-inhibitors-smooth-sailing-or-a-little-turbulence-ahead
#1
Robert A Hegele
No abstract text is available yet for this article.
May 5, 2017: Lancet Diabetes & Endocrinology
https://www.readbyqxmd.com/read/28461160/can-vitamin-d-prevent-falls-and-fractures
#2
Roger Bouillon
No abstract text is available yet for this article.
April 28, 2017: Lancet Diabetes & Endocrinology
https://www.readbyqxmd.com/read/28461159/effect-of-monthly-high-dose-vitamin-d-supplementation-on-falls-and-non-vertebral-fractures-secondary-and-post-hoc-outcomes-from-the-randomised-double-blind-placebo-controlled-vida-trial
#3
Kay-Tee Khaw, Alistair W Stewart, Debbie Waayer, Carlene M M Lawes, Les Toop, Carlos A Camargo, Robert Scragg
BACKGROUND: Adults with low concentrations of 25-hydroxyvitamin D (25[OH]D) in blood have an increased risk of falls and fractures, but randomised trials of vitamin D supplementation have had inconsistent results. We aimed to assess the effect of high-dose vitamin D supplementation on fractures and falls. METHODS: The Vitamin D Assessment (ViDA) Study was a randomised, double-blind, placebo-controlled trial of healthy volunteers aged 50-84 years conducted at one centre in Auckland, New Zealand...
April 28, 2017: Lancet Diabetes & Endocrinology
https://www.readbyqxmd.com/read/28456417/global-economic-burden-of-diabetes-and-its-implications
#4
Ping Zhang, Edward Gregg
No abstract text is available yet for this article.
April 26, 2017: Lancet Diabetes & Endocrinology
https://www.readbyqxmd.com/read/28456416/the-global-economic-burden-of-diabetes-in-adults-aged-20-79-years-a-cost-of-illness-study
#5
Christian Bommer, Esther Heesemann, Vera Sagalova, Jennifer Manne-Goehler, Rifat Atun, Till Bärnighausen, Sebastian Vollmer
BACKGROUND: Differences in methods and data used in past studies have limited comparisons of the cost of illness of diabetes across countries. We estimate the full global economic burden of diabetes in adults aged 20-79 years in 2015, using a unified framework across all countries. Our objective was to highlight patterns of diabetes-associated costs as well as to identify the need for further research in low-income regions. METHODS: Epidemiological and economic data for 184 countries were used to estimate the global economic burden of diabetes, regardless of diabetes type...
April 26, 2017: Lancet Diabetes & Endocrinology
https://www.readbyqxmd.com/read/28462871/correction-to-lancet-diabetes-endocrinol-2017-5-325-26
#6
(no author information available yet)
No abstract text is available yet for this article.
April 24, 2017: Lancet Diabetes & Endocrinology
https://www.readbyqxmd.com/read/28462870/has-the-uk-really-become-iodine-sufficient
#7
Sarah C Bath, Margaret P Rayman
No abstract text is available yet for this article.
April 24, 2017: Lancet Diabetes & Endocrinology
https://www.readbyqxmd.com/read/28462869/web-based-cognitive-behavioural-therapy-blended-with-face-to-face-sessions-for-chronic-fatigue-in-type-1-diabetes-a-multicentre-randomised-controlled-trial
#8
Juliane Menting, Cees J Tack, Arianne C van Bon, Henry J Jansen, Joop P van den Bergh, Marc J T M Mol, Martine M Goedendorp, Rogier Donders, Hans Knoop
BACKGROUND: Fatigue in type 1 diabetes is prevalent and persistent, but so far, no evidence-based treatments are available. We aimed to investigate the efficacy of cognitive behavioural therapy (CBT) in reducing fatigue severity in patients with type 1 diabetes. METHODS: We did a multicentre randomised controlled trial at one university medical centre and four large teaching hospitals in the Netherlands. Eligible patients were aged 18-70 years and had type 1 diabetes for at least 1 year and chronic fatigue for at least 6 months...
April 24, 2017: Lancet Diabetes & Endocrinology
https://www.readbyqxmd.com/read/28462868/fatigue-in-type-1-diabetes-an-understudied-problem
#9
Frans Pouwer
No abstract text is available yet for this article.
April 24, 2017: Lancet Diabetes & Endocrinology
https://www.readbyqxmd.com/read/28433343/guidelines-for-type-2-diabetes-keeping-a-finger-on-the-pulse
#10
LETTER
Anthony H Barnett, Paul O'Hare, Julian Halcox
No abstract text is available yet for this article.
April 19, 2017: Lancet Diabetes & Endocrinology
https://www.readbyqxmd.com/read/28408323/apolipoprotein-a-isoform-size-lipoprotein-a-concentration-and-coronary-artery-disease-a-mendelian-randomisation-analysis
#11
Danish Saleheen, Philip C Haycock, Wei Zhao, Asif Rasheed, Adam Taleb, Atif Imran, Shahid Abbas, Faisal Majeed, Saba Akhtar, Nadeem Qamar, Khan Shah Zaman, Zia Yaqoob, Tahir Saghir, Syed Nadeem Hasan Rizvi, Anis Memon, Nadeem Hayyat Mallick, Mohammad Ishaq, Syed Zahed Rasheed, Fazal-Ur-Rehman Memon, Khalid Mahmood, Naveeduddin Ahmed, Philippe Frossard, Sotirios Tsimikas, Joseph L Witztum, Santica Marcovina, Manjinder Sandhu, Daniel J Rader, John Danesh
BACKGROUND: The lipoprotein(a) pathway is a causal factor in coronary heart disease. We used a genetic approach to distinguish the relevance of two distinct components of this pathway, apolipoprotein(a) isoform size and circulating lipoprotein(a) concentration, to coronary heart disease. METHODS: In this mendelian randomisation study, we measured lipoprotein(a) concentration and determined apolipoprotein(a) isoform size with a genetic method (kringle IV type 2 [KIV2] repeats in the LPA gene) and a serum-based electrophoretic assay in patients and controls (frequency matched for age and sex) from the Pakistan Risk of Myocardial Infarction Study (PROMIS)...
April 10, 2017: Lancet Diabetes & Endocrinology
https://www.readbyqxmd.com/read/28408322/what-role-for-lipoprotein-a-in-clinical-practice
#12
Stephen J Nicholls, Peter J Psaltis
No abstract text is available yet for this article.
April 10, 2017: Lancet Diabetes & Endocrinology
https://www.readbyqxmd.com/read/28365412/tightening-our-understanding-of-intensive-glycaemic-control
#13
William G Herrington, David Preiss
No abstract text is available yet for this article.
March 29, 2017: Lancet Diabetes & Endocrinology
https://www.readbyqxmd.com/read/28365411/effects-of-intensive-glucose-control-on-microvascular-outcomes-in-patients-with-type-2-diabetes-a-meta-analysis-of-individual-participant-data-from-randomised-controlled-trials
#14
Sophia Zoungas, Hisatomi Arima, Hertzel C Gerstein, Rury R Holman, Mark Woodward, Peter Reaven, Rodney A Hayward, Timothy Craven, Ruth L Coleman, John Chalmers
BACKGROUND: Intensive glucose control is understood to prevent complications in adults with type 2 diabetes. We aimed to more precisely estimate the effects of more intensive glucose control, compared with less intensive glucose control, on the risk of microvascular events. METHODS: In this meta-analysis, we obtained de-identified individual participant data from large-scale randomised controlled trials assessing the effects of more intensive glucose control versus less intensive glucose control in adults with type 2 diabetes, with at least 1000 patient-years of follow-up in each treatment group and a minimum of 2 years average follow-up on randomised treatment...
March 29, 2017: Lancet Diabetes & Endocrinology
https://www.readbyqxmd.com/read/28320585/what-research-is-needed-to-address-the-co-epidemics-of-hiv-and-cardiometabolic-disease-in-sub-saharan-africa
#15
Pascal Geldsetzer, Jennifer Manne-Goehler, Till Bärnighausen, Justine Ina Davies
No abstract text is available yet for this article.
March 17, 2017: Lancet Diabetes & Endocrinology
https://www.readbyqxmd.com/read/28258842/gestational-diabetes-in-the-first-trimester-is-early-testing-justified
#16
Arianne N Sweeting, Glynis P Ross, Jon Hyett, Jencia Wong
No abstract text is available yet for this article.
February 28, 2017: Lancet Diabetes & Endocrinology
https://www.readbyqxmd.com/read/28434494/correction-to-lancet-diabetes-endocrinol-2017-5-174-83
#17
(no author information available yet)
No abstract text is available yet for this article.
May 2017: Lancet Diabetes & Endocrinology
https://www.readbyqxmd.com/read/28434493/correction-to-lancet-diabetes-endocrinol-2017-5-240-41
#18
(no author information available yet)
No abstract text is available yet for this article.
May 2017: Lancet Diabetes & Endocrinology
https://www.readbyqxmd.com/read/28434492/correction-to-lancet-diabetes-endocrinol-2017-5-125-33
#19
(no author information available yet)
No abstract text is available yet for this article.
May 2017: Lancet Diabetes & Endocrinology
https://www.readbyqxmd.com/read/28434491/semaglutide-lipid-lowering-drugs-and-nafld-author-s-reply
#20
LETTER
Christopher Sorli
No abstract text is available yet for this article.
May 2017: Lancet Diabetes & Endocrinology
journal
journal
47944
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"